Quantbot Technologies’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
Quantbot Technologies's TRML Position: Q4 2025 in Review
Quantbot Technologies sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 1,948 shares — an estimated $93.2K sold.
Quantbot Technologies first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $93.2K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.
- Quantbot Technologies reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
- Quantbot Technologies sold 1,948 Tourmaline Bio shares in Q4 2025, an estimated $93.2K.
- Quantbot Technologies first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
- Quantbot Technologies's Tourmaline Bio position peaked at $93.2K in Q3 2025.
- 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.
Based on Quantbot Technologies's 13F filing for Q4 2025, filed 10 Feb 2026.